Changes in hepatitis B antibody status after chemotherapy in children with acute lymphoblastic leukemia
- 25 August 2019
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (12) , e27904
Abstract
Background: Children with cancer may be at an increased risk of infection with hepatitis B virus (HBV) when levels of hepatitis B antibodies are reduced owing to chemotherapy‐induced immunosuppression. This study evaluated the changes in HBV antibody status and HBV infections after chemotherapy in children with acute lymphoblastic leukemia (ALL).Procedure: The data of patients with ALL diagnosed between April 2007 and March 2013 were retrospectively collected. Hepatitis B surface antibody (HBsAb) titers were defined as negative at levels P = .009).Conclusion: This study demonstrated that patients with a low level of prechemotherapy HBsAb titers were likely to become HBsAb negative after chemotherapy. Therefore, evaluation of HBsAb status may be necessary after the completion of chemotherapy in children with ALL.Keywords
This publication has 28 references indexed in Scilit:
- Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort studyThe Lancet Oncology, 2010
- HUMORAL IMMUNITY AGAINST HEPATITIS B, TETANUS, AND DIPHTHERIA FOLLOWING CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCIES: A Report and Review of LiteraturePediatric Hematology and Oncology, 2010
- Impacts of Vaccination on Hepatitis B Viral Infections in Korea over a 25-Year PeriodIntervirology, 2010
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study CohortJournal of Clinical Oncology, 2009
- Association Between Hepatitis B Virus and Pancreatic CancerJournal of Clinical Oncology, 2008
- A mathematical model to estimate global hepatitis B disease burden and vaccination impactInternational Journal of Epidemiology, 2005
- Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimensThe Journal of Pediatrics, 2005
- Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyCancer, 2004
- Recovery of Blood T-Cell Subsets After Chemotherapy for Childhood Acute Lymphoblastlc LeukemiaPediatric Hematology and Oncology, 1994
- Vaccination aginst chronic viral carriage in The GambiaThe Lancet, 1991